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Abstract: Amphibians are generally less sensitive than mammals to the acute toxicity of 
organophosphorus (OP) insecticides, but the basis for these differences is unclear. This 
study compared in vivo sensitivity of a mammal (Mus musculus, CD-1 outbred) and an 
amphibian (the Great Plains toad, Anaxyrus cognatus) to chlorpyrifos oxon (CPO), the 
active metabolite of the organophosphorus pesticide chlorpyrifos. Following 
intraperitoneal dosing, adult male toads were about 13-fold less sensitive to CPO than 
adult male mice based on acute maximum tolerated doses (MTDs). At equi-toxic doses 
(0.6, 0.8 or 1 x MTD), brain acetylcholinesterase (AChE) inhibition was noted in mice 
but not in toads. In contrast, fatty acid amide hydrolase (FAAH) in liver was inhibited by 
CPO in both species. Carboxylesterase, a common enzyme involved with OP 
detoxification, was undetectable in toad brain. Toad brain AChE was about 15-fold less 
sensitive in vitro to inhibition by CPO than mouse enzyme (IC50, 20 min at 37ºC: 136 vs 
9 nM), roughly agreeing with in vivo differences in sensitivity. We used an indirect 
inhibition assay to evaluate possible species differences in target-site detoxification of 
CPO. Toad brain homogenate was markedly more effective at inactivating CPO in vitro 
than an equivalent amount of mouse brain. These data suggest that the relative 
insensitivity of toad brain AChE to CPO contributes to the resistance to acute toxicity and 
may be due to more effective target-site detoxification. 
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CHAPTER I 
 
 
INTRODUCTION 
 
Organophosphorus (OP) compounds have been extensively used in agriculture, 
industry and public health over the last six decades (Grube et al., 2011; Atwood and 
Paisley-Jones, 2017). Some OPs have also been used as agents of warfare and terrorism. 
An OP insecticide (naled, 1,2-dibromo-2,2-dichloroethylphosphate) is currently being 
used to control Aedes aegypti in the US as the concern for an outbreak of the Zika virus 
increases, raising public concern over unwanted effects of insecticide use even in the face 
of a possible viral epidemic. The risks of untoward effects of OP pesticides to humans 
and the environment are legitimately weighed against the public health benefits of 
controlling insect vectors of disease (Pope et al., 2005). In contrast, the notorious use of 
OPs in chemical warfare and terrorism is of no benefit to society; concern over such uses 
continues today (Rosman et al., 2014).  
  OP compounds are most widely used as insecticides, contributing to a substantial 
portion (~33%) of insecticide use in the US (Atwood and Paisley-Jones, 2017). The OP 
insecticide chlorpyrifos (diethyl 3,5,6-trichloropyridinyl phosphorothioate), first 
introduced in 1965, is still widely used in the US and abroad (Giesy et al., 2014). 
According to USDA survey estimates, at least three million pounds of chlorpyrifos alone
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were applied in the US in 2015 (USDA-NASS, 2016). Because OPs are used extensively 
as pesticides, they can be common environmental contaminants (Ecobichon, 2001; 
Gilliom, 2007; Giesy et al., 2014). While OP pesticides can be highly effective against 
“pests,” their widespread use and presence in the environment creates opportunities for 
exposure and toxicity in non-target species.  
 The potential for OP exposure in wildlife necessitates the assessment of the risk 
OPs pose. One of the challenges faced in such risk assessments is interspecies variation 
in sensitivity. While direct comparisons of OP toxicity between species are relatively 
rare, the current literature demonstrates substantial variation in sensitivity to acute OP 
toxicity across numerous wildlife species, with the general trend that avian species are 
highly sensitive, mammals are moderately sensitive, and herpatofauna and piscine species 
are less sensitive (Wallace, 1992). Because the number of wildlife species is prohibitively 
great for comprehensive toxicity testing, risk assessment has traditionally relied on a 
small number of surrogate species. Therefore, understanding the factors that contribute to 
differential sensitivity may help us better understand phylogenetic differences between 
species as well as increase the validity of risk assessments.  
 The primary mechanism of acute OP toxicity is initiated by the inhibition of 
acetylcholinesterase (AChE), the enzyme responsible for the hydrolysis of the 
neurotransmitter acetylcholine (ACh) at cholinergic synapses (Quinn, 1987). Upon 
cholinergic neuron depolarization, ACh is released at the presynaptic terminal to activate 
cholinergic receptors on postsynaptic neurons, muscle cells or autonomic effector organs 
(Costa, 1988). Acetylcholinesterase, one of the most catalytically efficient enzymes in the 
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body, is strategically located within cholinergic synapses to degrade ACh and terminate 
cholinergic signaling. 
 Organophosphorus anticholinesterases interact with AChE (and other serine 
hydrolases) in a similar manner as the natural substrate (Aldridge and Reiner, 1972). The 
active site serine hydroxyl group engages in nucleophilic attack on the carbon atom of 
ACh or the phosphorus atom of an OP, leading to acyl intermediates in both cases 
(Richardson et al., 2009). With the substrate ACh, hydrolysis of the acyl intermediate 
(and consequent reactivation of the enzyme) occurs very rapidly. When OPs are bound, 
however, hydrolysis of the acyl intermediate is exceedingly slow, leading to long-term 
inactivation of the enzyme (Aldridge and Reiner, 1972). It should be noted that given 
sufficient time, the phosphylated enzyme will reactivate, i.e., it is generally not 
“irreversibly” inhibited, even though OPs are routinely referred to as irreversible AChE 
inhibitors. Spontaneous reactivation of the inhibited enzyme is frequently so slow that 
recovery of ACh hydrolysis following OP intoxication is primarily mediated by de novo 
synthesis of new enzyme molecules (Main, 1964). In some cases, however, the bound 
OP-enzyme complex can undergo an “aging” reaction that strengthens the phosphorus-
enzyme bond and prevents reactivation, leaving the enzyme now indeed irreversibly 
inhibited (Richardson et al., 2009).  
 Cholinergic signaling participates in a wide range of functions throughout the 
nervous system of vertebrates and invertebrates (Massoulie and Bon, 1982). When an OP 
is covalently bound to the active site serine residue of AChE, the enzyme can no longer 
catalyze the hydrolysis of ACh. Sufficient inhibition of enzymes within the synapses 
leads to ACh accumulation and excessive stimulation of cholinergic receptors (Fukuto, 
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1990). Classic signs of acute cholinergic toxicity with extensive AChE inhibition can be 
separated into peripheral and central nervous system effects. Excessive stimulation of 
muscarinic receptors within the peripheral nervous system may increase autonomic 
secretions (salivation, lacrimation, urination and defecation; SLUD signs) and induce 
bradycardia and miosis (Gaines, 1960; Pope, 2006). Tremors and muscle fasciculations 
are caused by over-stimulation of nicotinic receptors in the peripheral nervous system. 
Additionally, cholinergic disruption in the central nervous system can result in seizure, 
coma, neuropathology and respiratory depression (Pope, 2006; Richardson et al., 2009; 
Pouliot et al., 2016). In mammals, lethality from severe OP poisoning is generally the 
result of asphyxiation caused by disruption of respiratory control in centers within the 
pons-medulla, excessive airway secretions and paralysis of the respiratory muscles (De 
Candole et al., 1953; Albuquerque et al., 1985).  
 The majority of OP pesticides are applied as “parent” compounds, requiring 
metabolic activation by mixed function oxidases (e.g., cytochrome P450s, flavin-
containing monooxygenases) for potent biocidal activity (Potter and O’Brien, 1964; 
Fukuto, 1990). For example, the insecticide chlorpyrifos has little anticholinesterase 
activity until converted by oxidative desulfuration to a much more reactive oxygen 
analog (i.e., chlorpyrifos oxon [3,5,6-trichloro-2-pyridinyl phosphate], Levi and 
Hodgson, 1992). Following metabolic activation of the parent OP compound the oxon is 
much more potent at inactivating AChE and other sensitive enzymes. Differential 
metabolic activation across species is one of many factors that contribute to differential 
sensitivity (Potter and O’Brien, 1964; Hitchcock and Murphy, 1971; Chambers and Carr, 
1995; Boone and Chambers, 1997). Species that more effectively activate parent OP 
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compounds generally have higher levels of toxic active metabolites, which can mediate 
higher sensitivity to cholinergic toxicity. 
 The variation in metabolic activation of parent compounds among species is 
somewhat consistent with, but cannot completely explain, differences in sensitivity.  
Despite variation within taxonomic groupings (Hitchcock and Murphy, 1971; Lavado and 
Schlenk, 2011), metabolic activation of OPs is generally more rapid in liver tissue of 
birds and mammals than in fish (Potter and O’Brien, 1964; Hitchcock and Murphy, 1971; 
Machin et al., 1975; Wallace and Dargan, 1987; Chambers and Carr, 1995). Differences 
in metabolic activation of OPs have also been reported between age groups within a 
single species. For example, juvenile rats have lesser metabolic activation towards OPs 
compared to adults; however, they also have lower detoxification capacity that 
contributes to their ultimately higher sensitivity (Pope et al., 1991; Zhang et al., 2002). 
The same trend of maturational decreases in sensitivity has also been reported in avian 
species. Wolfe and Kendall (1998) reported that nestlings of both European starlings 
(Sturnus vulgaris) and red-winged blackbirds (Agelaius phoeniceus) are more sensitive to 
OP intoxication compared to adults; however, the underlying mechanism of this 
difference is still unclear.  
The chemical structure of an OP can also influence metabolism. Certain OPs can 
be preferentially metabolized by cytochrome P450s or monooxygenases, partially 
explaining why some OP insecticides are more toxic than others (Sultatos et al., 1985; 
Wallace and Kemp, 1991). For example, mallard (Anas platyrhynchos) liver enzymes 
preferentially bioactivate methyl parathion relative to parathion and fenitrothion 
(Thompson et al., 1995). Variation in chemical structure also influences OP activation in 
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mammals (Machin et al., 1975; Chambers and Carr, 1995) and fish (Lavado and Schlenk, 
2011). For example, mosquitofish (Gambusia affinis) liver microsomes bioactivate 
chlorpyrifos more readily than parathion (Boone and Chambers, 1997). 
Metabolic activation of OPs alone cannot explain the differences in sensitivity 
among species. If sensitivity was strictly related to metabolic activation, one would 
expect rodents to be the most sensitive group, as they typically have higher rates of 
activation for OPs in vitro (Hitchcock and Murphy, 1971; Poet et al., 2003). This is not 
the case, however, as avian species with comparatively lower bio-activation rates are still 
more sensitive compared to rodents in vivo (Wallace, 1992; Barron and Woodburn, 1995; 
Crane et al., 2016). Together, this evidence suggests that other factors can have a 
prominent role in determining differential sensitivity to OP toxicity.  
Detoxification processes can determine how quickly OPs are inactivated, and thus 
influence species sensitivity to OP toxicity. Oxons are hydrolyzed primarily by non-
specific esterases. Aldridge (1953) defined esterases able to hydrolyze OPs as “A-
esterases,” e.g., paraoxonase. Esterases that are inhibited by OPs were termed “B-
esterases,” e.g., acetylcholinesterase and butyrylcholinesterase. The relative activities of 
A-esterases in mammalian tissues have been exhaustively investigated as they are 
implicated in the detoxification of nerve agents and pesticides in humans (Li et al., 2005). 
Mammals generally express higher A-esterase levels than other taxonomic groups 
(Chambers and Carr, 1995). In contrast, birds are generally low in plasma A-esterase 
levels compared to mammals, which correlates with their higher sensitivity to OPs 
(Brealy et al., 1980; Wolfe and Kendall, 1998; Crane et al., 2016). Conversely, the role of 
A-esterases in sensitivity of amphibians and reptiles has not been extensively 
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investigated. Some studies suggested that amphibians have higher levels of A-esterases, 
allowing them to effectively inactivate OPs (Edery and Schartzberg-Porath, 1960). 
Despite relatively high serum A-esterase levels, mammals tend to be more sensitive to 
OP intoxication than fish and herpatofauna (Murphy, 1966; Barron and Woodburn, 
1995). This suggests that, while detoxification is clearly an important factor in 
determining sensitivity, A-esterases are not the primary determinant of species sensitivity 
to OP intoxication. 
The relative density of non-target B-esterases (i.e., OP-sensitive enzymes other 
than AChE) can also play a role in comparative sensitivity. Acetylcholinesterase is a 
member of the serine hydrolase superfamily of enzymes, which share a common 
“catalytic triad” of residues at the active site (for review, see Bachovochin and Cravatt, 
2012). Butyrylcholinesterase (BChE; the “sister” enzyme to AChE) and 
carboxylesterases (CbE) are other serine hydrolases capable of binding to and 
inactivating OP insecticides (Lockridge, 2015). Several additional serine hydrolases, such 
as the two primary endocannabinoid-degrading enzymes, monoacylglycerol lipase 
(MAGL) and fatty acid amide hydrolase (FAAH) are also sensitive to covalent 
modification by OPs and may contribute to non-AChE consequences of OP intoxication 
(Nallapaneni et al., 2008; Pope et al., 2010). While none of these enzymes are capable of 
hydrolyzing OPs, they present stoichiometric binding sites that can sequester toxic OP 
molecules and lessen AChE inhibition. Genomic studies reveal that the endocannabinoid 
system is highly conserved in vertebrates (for review, see Cottone et al., 2008; Fezza, 
2014), but its function has not been extensively investigated in non-mammalian models, 
including amphibians. As such, these enzymes and their possible contribution to 
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differential sensitivity have not been investigated in amphibians exposed to OP 
insecticides.  
While differences in metabolic activation and detoxification of OPs can contribute 
to interspecies variation in sensitivity, it is accepted that interactions at the target site (i.e., 
toxicodynamic factors) are the most important determinant of species sensitivity 
(Wallace, 1992).  The complete reaction from free to phosphylated enzyme is described 
by the bimolecular rate constant (ki); once phosphylated, the enzyme-OP complex can 
either age (becoming irreversibly inhibited) or undergo spontaneous reactivation 
(Richardson et al., 2009). Comparative kinetic studies suggest that there are substantial 
interspecies differences in the kinetics of AChE inhibition by OPs, with the more 
sensitive species displaying more rapid phosphylation (Andersen et al., 1977; Wang and 
Murphy, 1982; Worek et al., 2011; Herket et al., 2011). Differences in chemical 
structures of OP compounds can also influence inhibition kinetics. For example, the rapid 
aging of the soman-AChE complex increases the nerve agent’s lethality compared to 
other anticholinesterases because of its resistance to reactivation (Berry and Davies, 
1966). The ki of AChE inhibition in the nervous system can predict relative sensitivity to 
OP toxicity.  
Several studies have reported that amphibians can be markedly less sensitive to 
acute OP toxicity compared to other taxonomic groups (Hawkins and Mendel, 1946; 
Edery and Schatzberg-Porath, 1960; Andersen et al., 1972; Hall and Kolbe, 1980; Shapira 
et al., 1998; Crane et al., 2016). The molecular basis for such differences in sensitivity 
among classes of vertebrates remains unclear. Amphibians are important members of 
many ecosystems, generally representing a large portion of the vertebrate biomass (Kerby 
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et al., 2010). Amphibians can often be found in and around agricultural landscapes, in 
part due to the widespread application and accumulation of water for irrigation, as well as 
to the transformation of habitats into farmland (Marsh et al., 2004; Knutson et al., 2004; 
Mazerolle et al., 2005). While many studies have attempted to link pesticide use with 
amphibian population declines (Sparling et al., 2001; Sparling and Fellers, 2009), 
terrestrial amphibians are often similarly or less sensitive than other wildlife species to 
some common organic insecticides (Kerby et al., 2010). In the case of OP insecticides, 
amphibians are generally markedly less sensitive than birds and mammals (Wang and 
Murphy, 1982; Crane et al., 2016). Most toxicological research investigating the effects 
of OPs in amphibians has been done in tadpoles and as such was focused more on 
developmental toxicity (for review, see Pechen de D’Angelo and Venturino 2005). This 
focus may be justifiable given that immature amphibians (tadpoles and metamorphs) are 
considered the most vulnerable subpopulation, but that emphasis has limited the 
understanding of differences in sensitivity in adults and their potential role in population 
changes.  
Edery and Schatzberh-Porath (1960) reported that toad (Bufo viridis) and frog 
(Pelophylax ridibundus) had up to 360-fold higher LD50 values compared to mouse (Mus 
musculus) after subcutaneous exposure to the OPs paraoxon or 
diisopropylfluorophosphate (DFP). Hudson and coworkers (1984) noted a much lower 
difference in sensitivity between amphibians and mammals with the OP pesticide 
chlorpyrifos, i.e., the oral LD50 for chlorpyrifos in American bullfrogs (Rana 
catesbeiana) was only 2.6-fold higher than in rats (Rattus norvegicus). Barron and 
Woodburn (1995) reported that the acute oral LD50 for chlorpyrifos was about 10-fold 
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higher in American bullfrogs than mallard ducks (Anas platyrhynchos). A recent meta-
analysis of acute oral toxicity by Crane and coworkers (2016) concluded that adult 
amphibians are generally less sensitive than birds and mammals to acute OP toxicity.  
Only a few studies have evaluated potential mechanisms that might contribute to 
differences in sensitivity between amphibians and mammals. Hawkins and Mendel 
(1946) reported that brain AChE from grass frog (Rana pipiens) was about 200-fold less 
sensitive to inhibition in vitro by the carbamate anticholinesterase physostigmine, 
compared to inhibition of the enzyme in brain tissue from either horse (Equus ferus) or 
mouse (Mus musculus). Edery and Schatzberh-Porath (1960) proposed that more 
effective detoxification by CbE may be important in the lower sensitivity exhibited by 
amphibians. More recently, Robles-Mendoza and coworkers (2011) noted that CbE in 
juvenile axolotls (Ambystoma mexicanum) was less sensitive than AChE to inhibition in 
vivo by chlorpyrifos. Attademo and coworkers (2017) suggested that intestinal CbE might 
contribute to detoxification of chlorpyrifos in tadpoles (Rhinella arenarum). The relative 
prevalence of non-target A- and B- esterases in amphibians and their contribution to 
sensitivity has not been resolved.  
Other investigators studied differences in sensitivity of AChE to inhibition by OP 
anticholinesterases in differential toxicity. Zahavi and coworkers (1971) investigated the 
basis for differential sensitivity to OP toxicity in toad (Bufo viridis), medfly (Ceratitis 
capitata), American cockroach (Periplaneta americana) and several strains of mites 
(Tetranychus cinnabarinus). They found that enzymes from species that had relatively 
low sensitivity in vivo (toads and OP-resistant mites) exhibited different substrate kinetics 
(i.e., lower Vmax and higher Km), which led to the proposal that the relative sensitivity of 
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AChE to anticholinesterses was correlated with structural differences in the active site 
region of the enzyme, which may in turn influence inhibitor interactions with the catalytic 
site.  
Shapira and coworkers (1998) studied acetylcholinesterase inhibition and acute 
toxicity in wild type Xenopus laevis larvae and mutants expressing human AChE. 
Interestingly, larvae expressing the human enzyme were more sensitive to acute paraoxon 
toxicity than the wild type larvae. In vitro differences in sensitivity to inhibition between 
the frog wild type and human enzyme were also noted with other inhibitors including 
pyridostigmine, DFP and tacrine. Shapira and coworkers (1998) also compared substrate 
inhibition, i.e., the reduction of enzyme activity in the presence of high concentrations of 
endogenous substrate (Reed et al., 2010), between wildtype X. laevis and human 
enzymes.  Kinetic analysis suggested a lack of substrate inhibition with the wildtype 
enzyme but not with the human enzyme. Thus, work by Zahavi and coworkers (1971), 
Shapira and colleagues (1998) suggest structural differences in AChE may lead to 
differences in substrate kinetics, which may in turn influence the relative resistance of 
amphibian AChE to inhibition by OPs.   
In summary, there are a variety of factors that can contribute to species 
differences in sensitivity to OPs. Comparative toxicity studies can improve risk 
assessment of pesticides and further our understanding of physiological differences 
between species. Despite their ecological significance and recent population declines, 
relatively little research has been conducted on acute OP toxicity in adult amphibians. A 
number of reports indicate that adult amphibians are relatively insensitive to acute OP 
toxicity compared to mammals, and that several factors could play a role. This project 
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compared acute sensitivity of a mammal (Mus musculus) and an amphibian (Anaxyrus 
cognatus) to chlorpyrifos oxon and investigated toxicodynamic and toxicokinetic factors 
that may contribute to amphibians’ reportedly low sensitivity. The specific aims were:  
1. to compare in vivo toxicity in mouse and toad following acute chlorpyrifos oxon 
exposure. 
2. to compare in vitro interactions of OP-sensitive enzymes with substrate and 
selected inhibitors. 
3. to screen for possible OP-binding proteins in mouse and toad brain that may  
contribute to differential toxicity. 
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CHAPTER II 
 
 
METHODS 
 
Chemicals 
Chlorpyrifos oxon (O, O’-diethyl O-3, 5, 6-trichloro-2-pyridinyl phosphate; 
CPO), paraoxon (O, O’-diethyl O-4 nitrophenyl phosphate) and naled (dimethyl-1, 2-
dibromo-2,2-dichlorethyl phosphate) were purchased from ChemService (West Chester, 
PA). Diisopropylfluorophosphate (DFP) was kindly provided by Derik Heiss at Batelle 
Memorial Institute (Columbus, OH). Stock solutions (10 mM) of these inhibitors were 
prepared in ethanol and stored desiccated under nitrogen at -70°C.  2-Arachidonoyl 
thioglycerol was purchased from Cayman Chemical Company (Ann Arbor, MI). FP-
Rhodamine (TAMRA-FP serine hydrolase probe) was purchased from Thermo Fisher 
Scientific (Waltham, MA). Coomassie Brilliant blue (R 250), glycine and kaleidoscope 
protein ladder were purchased from Bio-Rad (Hercules, CA). Octanoyl-methoxypyridine 
was a generous gift from Dr. Bruce Hammock at University of California (Davis, CA). 
Peanut oil was from Lou Ana Oils (Brea, CA). Acetylthiocholine and all other reagents 
were purchased from Sigma-Aldrich (St. Louis, MO). 
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Animals  
Male outbred CD-1 mice (Mus musculus; eight weeks of age) were purchased 
from Charles River (Wilmington, MA). Mice were maintained in shoebox cages with 
standard rodent chow and water available ad libitum under a 12-12 hour light-dark cycle. 
Sexually mature male and female Anaxyrus cognatus were hand-collected from Blaine, 
Logan, Garfield and Kingfisher Counties, OK during April and May 2015-6. Toads were 
transported back to an animal housing facility at Oklahoma State University and kept in 
same-sex groups in 75 L aquaria with moist sand (> 5 cm deep). Toads were fed weekly 
with mealworms (Tenebrio molitor) ad libitum dusted with Miner-All (Sticky Tongues 
Farm, Sun City, CA) and provided continuous access to bowls of dechlorinated water 
under 12-12 hour light-dark cycle. All animals were acclimated to housing conditions for 
at least five days prior to dosing or tissue collection for in vitro studies. Toads were 
euthanized by immersion in buffered MS-222 (tricaine methane sulfonate, 0.5%, pH 7) 
followed by decapitation. Mice were euthanized by decapitation using a guillotine. Brain 
and liver tissues were collected from both species and frozen at -70°C for subsequent 
biochemical assays. All procedures were approved by the Oklahoma State University 
Institutional Animal Care and Use Committee and conducted in AAALAC accredited 
facilities. 
Maximum Tolerated Dose Estimation 
To compare mouse and toad sensitivity to CPO, we estimated maximum tolerated 
doses (MTD). Rate of OP activation (i.e., conversion of parent insecticide to active 
metabolite) can influence relative sensitivity between groups (Chambers and Carr 1995). 
As there is little information on the relative activation of OPs between mammals and 
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amphibians, we used CPO (the active oxon metabolite of chlorpyrifos) for comparative 
toxicity studies. An up-and-down method was used to estimate CPO toxicity (Bruce et 
al., 1987).  One animal was treated (intraperitoneal injection; ip) with an initial dose (10 
mg/kg for mice; 100 mg/kg for toads; dissolved in peanut oil, 3 mL/kg). If the animal 
survived for 24 hours, the subsequent animal received 1.3 x that dose. If the first dose 
was lethal, the next animal was given 0.77 x the first dose. This process was repeated 
until an animal died (going up in dose) or survived (going down in dose), yielding an 
MTD. This estimate was used in the following acute toxicity studies. Morbidity in toads 
was evaluated through loss of righting reflex and gross evaluation of cardiac chest 
movements.  
Acute Toxicity  
Toads and mice were divided into four experimental groups: 0, 0.6, 0.8 and 1 x 
the respective MTD. The control groups received only vehicle (peanut oil; 3 mL/kg). 
Animals were weighed, dosed and monitored at regular intervals (0.5, 1, 2, 4, 8 and 24 
hours). Four hours after dosing, animals were scored for involuntary movements 
following the methods of Moser and coworkers (1995), modified by Liu and Pope 
(1996). For involuntary movements, animals were scored as follows: 2, normal 
movements; 3, mild fine tremors or head and forelimbs; 4, whole-body tremors; 5, 
myoclonic jerks. For SLUD signs, animals were scored as follows: 1, normal (no 
secretions); 2, one or two mild secretions; 3, multiple moderate secretions; 4, multiple 
severe secretions. Twenty-four hours after dosing, animals were weighed and sacrificed.  
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In acute lethality studies, we observed that the toads became hypo-active and 
unresponsive to handling. To quantify possible loss of coordination in a uniform manner 
that could be compared between species, we designed a “tilt test.” A shoebox cage (28 x 
17 x 12 cm) was attached to a platform on a hinge, allowing the cage to be tilted in a 
continuous manner. Four hours after dosing, animals were individually placed in the cage 
that was then raised steadily along the hinge until the animal either: 1) lost balance and 
fell to the lower end of cage or 2) moved to the lower end of the cage on their own 
volition. For consistency, animals were always placed facing away from the hinge and 
towards the “upper” (the end that would be raised) end of the cage. The maximum 
positive angle (°) each animal maintained was measured using a protractor. Trials were 
video recorded and scored by an investigator blinded to the treatment groups. We 
expected that intoxicated animals would be less coordinated and therefore slide to the 
bottom of the cage at lower inclines than control animals.  
Biochemical Assays  
Brain and liver tissues were homogenized in ice-cold phosphate-buffered saline, 
pH 7 at 30,000 RPM for 20 seconds using a Polytron PT 3100 (Kinematica AG; 
Switzerland) prior to enzyme assays. Liver homogenates were centrifuged at 1,000 x g at 
4°C for 10 min using an Avanti J-25I centrifuge (Beckman Coulter; Indianapolis, IN), 
and supernatants were used for subsequent assays. 
Acetylcholinesterase (brain), BChE (brain and liver) and MAGL (brain and liver) 
activities were measured using a photometric method similar to Ellman et al. (1961) and 
Ulloa and Deutsch (2010) as modified by Liu and Pope (2015). A cocktail of substrate 
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(final concentrations: acetylthiolcholine, 1 mM; butyrylthiocholine, 1 mM; 2-
arachidonoyl thioglycerol, 0.1 mM) and DTNB (0.1 mM final) was added to tissue 
homogenates with 10 mM Tris buffer with 1 mM EDTA (pH 7.2; Tris-E) in a final 
reaction volume of 200 µl and activity was measured kinetically at 412 nm for 5 min at 
37°C using a SpectraMax 340 PC plate reader (Molecular Devices; Sunnyvale, CA). 
Carboxylesterase (brain and liver) activity was measured following the method of 
Clement and Erhardt (1990) as modified by Chanda and coworkers (1997). Substrate (p-
nitrophenyl acetate; 250 µM final) was added to tissue homogenates with Tris-E buffer 
(pH 7.2) in a final reaction volume of 200 µl and activity was monitored kinetically at 
405 nm for 5 min at 37°C.   
Fatty acid amide hydrolase (brain and liver) activity was measured following the 
fluorometric method of Huang et al. (2007). Tissues were incubated with the substrate 
octanoyl-methoxypyridine (50 µM final) in 125 mM sodium phosphate buffer (pH 8, 1% 
glycerol, 0.1% Triton X-100) in a final reaction volume of 200 µl for 30 min at 37°C. 
Formation of hydrolysis product was measured fluorometrically (excitation: 320 nm, 
emission: 396 nm) using a SpectraMax M2 plate reader (Molecular Devices; Sunnyvale, 
CA). All enzyme activities were normalized by protein content using the method 
described by Bradford (1976).  
In vitro sensitivity of mouse and toad AChE to OP inhibitors was determined by 
first pre-incubating tissue homogenates with vehicle or one of a range of OP 
concentrations (CPO: 0.5 – 1,000 nM; paraoxon: 1 – 50,000 nM; naled: 1 – 5,000 nM) at 
37°C for 20 min, and then measurement of residual activity as described above. Control 
samples were pre-incubated with vehicle (ethanol; 0.5% final, v/v) to estimate 100% 
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activity. IC50 (the concentration of inhibitor that depresses enzyme activity by 50%) 
values were determined through non-linear regression (log inhibitor vs. % control- 
variable slope: four parameters) using GraphPad Prism (Version 6.0).  Some assays 
compared sensitivity of mouse and toad AChE to CPO (0.5 – 1,000 nM) at 26°C (20 min) 
in order to evaluate the influence of temperature on interactions between enzymes and 
inhibitors.  
Substrate Kinetics 
Substrate kinetic parameters (km and Vmax) for acetylcholinesterase were 
compared by incubating tissues (37°C) with varying concentrations of acetylthiocholine 
(10 – 1,000 µM) and monitoring results kinetically (10 min, 37°C). Parameters were 
determined through non-linear regression of enzyme velocity vs substrate concentration, 
according to the Michaelis-Menten equation using GraphPad Prism (Version 6.0).  
OP Inactivation Assay 
The ability of a tissue to detoxify OP compounds was measured by an indirect 
inhibition assay (Chanda et al., 1997; Karanth et al., 2001). Either buffer or tissue 
homogenate (2.5 mg tissue) was pre-incubated (15 min; 37°C) with varying 
concentrations of CPO (3 – 800 nM final) in 200 mM Tris-HCl buffer (pH 7.8) in a final 
volume of 250 µl. A marker enzyme (purified recombinant human BChE; 250 ng) was 
then added and further incubated for 20 min (37°C). Residual BChE activity was then 
measured photometrically as described above. Residual BChE activity was used as an 
indicator of tissue OP inactivation.  
 
19 
 
Screening for OP-Sensitive Proteins in Brain Tissue 
To identify potential enzymes that may contribute to differential OP inactivation 
in mouse and toad brain tissue, we used a fluorescent serine hydrolase probe as described 
by Nomura and Casida (2011). In brief, 2 mL of 1:25 brain tissue homogenate was 
centrifuged at 1,000 x g for 10 min (4°C) using an Avanti J-25I centrifuge (Beckman 
Coulter; Indianapolis, IN). The supernatant was removed and spun again at 10,000 x g for 
10 min (4°C). The resulting membrane pellet (P2) was homogenized in 200 µl ice-cold 50 
mM Tris-HCl (pH 7.4) and pre-incubated with vehicle (ethanol, 0.5% final, v/v) or CPO 
(1, 10, 100 nM final; 20 min; 37°C). FP-rhodamine (4 µM final) was then added and 
incubated for 30 min (23°C). The reaction was stopped by the addition of loading buffer 
(30 µl) and then heat inactivated at 90°C for 10 min. Ten percent polyacrylamide gels 
(0.1% SDS) with 4.5% stacking gels, 1 mm thick, were poured in a Mini-protean Tetra 
cell casting stand (Bio-Rad; Hercules, CA). Samples (10 µl/well) were loaded and 
separated at 120 V for two hours using a Mini-protean Tetra PowerPac Universal supply 
system (Bio-Rad; Hercules, CA).  
Gels were fluorometrically visualized using a Cy 3 filter (excitation: 552 nm, 
emission: 575 nm) with an Amersham Imager 600 (GE Healthcare Bio-Sciences; 
Pittsburg, PA). FP-rhodamine labels serine hydrolases, so the absence of fluorescent 
bands in CPO-exposed tissues can indicate CPO-sensitive proteins. Fluorescent probe 
gels were stained by washing in 50% methanol, 10% acetic acid, 25% Coomassie 
Brilliant blue (R 250; w/v) with shaking for one hour and then de-stained in 10% acetic 
with shaking for eight hours. CPO-sensitive bands from toad brain were excised, digested 
and proteins were identified using LC/MS-MS.  
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Data Analysis 
All in vivo enzyme and tilt test data were presented as mean + SEM and were 
analyzed for significance by one-way analysis of variance (ANOVA); significant main 
effects were followed by post hoc Dunnett’s multiple comparisons. Involuntary 
movement and SLUD scores were presented as median with interquartile range and were 
analyzed for significance using a Kruskal-Wallace one-way ANOVA. IC50 values for 
single inhibitors and inactivation assays were presented as mean and 95% confidence 
intervals. Substrate kinetic constants (km, Vmax) were presented as mean + SEM and 
compared between species using an unpaired Student’s T-test. In all comparisons, p < 
0.05 was used to indicate statistical significance. All statistical approaches were 
conducted using GraphPad Prism (software version 6.0). 
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CHAPTER III 
 
 
RESULTS 
 
Maximum Tolerated Dose 
Toads were markedly less sensitive to CPO than mice. The maximum tolerated 
dose of CPO was 13-fold higher in toads than in mice (77 vs 5.9 mg/kg). Functional signs 
of toxicity were noted in both species treated with respective MTDs (summarized in 
Table 1). In mice, we observed pronounced involuntary movements, muscular 
fasciculations and SLUD signs at doses greater than 4.7 mg/kg. During acute lethality 
studies, toads (n = 2) that received 100 mg/kg of chlorpyrifos oxon displayed pronounced 
miosis and parotoid secretions (both thick white and thin clear secretions); however, 
these signs were not observed with lower doses. In toads, no involuntary movements, 
tremors or muscle fasciculations were noted. Instead, we observed hypo-activity and 
excessive salivation at the highest dose (100 mg/kg). 
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Acute Toxicity  
The acute toxicity study used increments of the respective MTD (0, 0.6, 0.8 and 1 
x MTD). Mice received 0, 3.6, 4.7 or 5.9 mg/kg CPO, while toads received 0, 46, 62 or 
77 mg/kg CPO. In mice, there was significant, dose-related inhibition of brain AChE (F3,4 
= 15.1 , p < 0.0001; Figure 1), BChE (F3,4 = 9.27, p = 0.0009; Figure 2), MAGL (F3,4 = 
3.58, p = 0.03; Figure 3), FAAH (F3,4 =19.4, p < 0.0001; Figure 4) and CbE (F3,4 = 10.6, p 
= 0.0004; Figure 5). In contrast, there was no significant change in any enzyme in toad 
brain. Even in the highest dose group (77 mg/kg), we observed no significant effect on 
toad brain AChE (F3,3 = 0.369, p = 0.78; Figure 1), BChE (F3,3 = 0.105, p = 0.96; Figure 
2) or MAGL (F3,3 = 0.227, p = 0.88; Figure 3). There was a significant main effect of 
treatment on toad brain FAAH (F3,3 = 5.68, p = 0.012; Figure 4), but no significant 
pairwise comparisons were noted. Carboxylesterase activity was undetectable in all 
control and treated toad brains. 
In liver, CPO did not inhibit BChE activity in either mouse (F3,4 = 0.437, p = 
0.734) or toad (F3,3 = 1.45, p = 0.28; Figure 6). Fatty acid amide hydrolase activity was 
significantly inhibited in the livers of both mice (F3,4 = 12.8, p = 0.0002) and toads (F3,3 = 
6.92, p = 0.0059; Figure 7). Neither mouse (F3,4 = 0.691, p = 0.57) nor toad liver CbE 
(F3,3 = 2.58, p = 0.10; Figure 8) was inhibited by CPO. Of note, basal CbE activity in 
mouse liver was >100-fold higher compared to activity in toad liver.  
Four hours after dosing, we evaluated the animals for involuntary movements and 
SLUD signs and conducted the tilt test. In mice, 4.7 and 5.9 mg/kg CPO elicited 
involuntary movements (p = 0.004), while no involuntary movements were noted in any 
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toads (Figure 9).  The higher dose (5.9 mg/kg CPO) induced SLUD signs in mice (p = 
0.02), while no SLUD signs were noted in toads (Figure 10). Mice and toads also 
responded differently in the tilt test. In toads, CPO exposure was associated with a higher 
incline with 62 and 77 mg/kg CPO (p = 0.02; Figure 11). With the controls and animals 
treated with the lowest dose (46 mg/kg), toads rapidly hopped to the lower end of the 
box, while at the two higher doses, toads failed to react and instead splayed their limbs 
and slid down the bottom surface of the box when the incline was sufficiently steep. 
Chlorpyrifos oxon did not influence the incline at which mice slid to the cage bottom 
(F3,4 =  2.26, p = 0.12; Figure 11). 
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Sign Mouse (10 mg/kg CPO) Toad (100 mg/kg CPO) 
Tremors + - 
Salivation + + 
Lacrimation + - 
Urination + - 
Defecation + - 
Miosis - + 
Erythema - + 
Parotoid Secretions NA + 
 
Table 1. Toxic signs in mouse and toad following single lethal dose of chlorpyrifos oxon 
(CPO). There were substantial differences in toxic signs between mice and toads. These 
data represent observations made during acute lethality studies. + indicates that the 
functional response was observed within 24 hours of dosing, while – indicates no 
response (n = 2).  
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Figure 1. Mouse and toad brain acetylcholinesterase (AChE) activities following acute 
chlorpyrifos oxon (CPO) exposure (ip). Mice were treated with either vehicle (peanut 
oil), 3.6, 4.7 or 5.9 mg/kg CPO. Toads were treated with either vehicle (peanut oil), 46, 
62 or 77 mg/kg CPO. CPO significantly inhibited brain AChE in mice, but had no 
significant effect on toad brain AChE. Data represent mean specific activity + SEM 
(mouse: n = 5; toad: n = 4). Asterisks indicate a significant difference compared to 
vehicle controls (p < 0.05).  
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Figure 2. Mouse and toad brain butyrylcholinesterase (BChE) activities following acute 
chlorpyrifos oxon (CPO) exposure (ip). Mice were treated with either vehicle (peanut 
oil), 3.6, 4.7 or 5.9 mg/kg CPO. Toads were treated with either vehicle (peanut oil), 46, 
62 or 77 mg/kg CPO. CPO significantly inhibited brain BChE in mice, but had no 
significant effect on toad brain BChE. Data represent mean specific activity + SEM 
(mouse: n = 5; toad: n = 4). Asterisks indicate a significant difference compared to 
vehicle controls (p < 0.05). 
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Figure 3. Mouse and toad brain monoacylglycerol lipase (MAGL) activities following 
acute chlorpyrifos oxon (CPO) exposure (ip). Mice were treated with either vehicle 
(peanut oil), 3.6, 4.7 or 5.9 mg/kg CPO. Toads were treated with either vehicle (peanut 
oil), 46, 62 or 77 mg/kg CPO. Chlorpyrifos oxon significantly inhibited brain MAGL in 
mice that received 5.9 mg/kg (1 x MTD), but had no significant effect on toad brain 
MAGL. Data represent mean specific activity + SEM (mouse: n = 5; toad: n = 4). 
Asterisk indicates a significant difference compared to vehicle control (p < 0.05). 
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Figure 4. Mouse and toad brain fatty acid amide hydrolase (FAAH) activities following 
acute chlorpyrifos oxon (CPO) exposure (ip). Mice were treated with either vehicle 
(peanut oil), 3.6, 4.7 or 5.9 mg/kg CPO. Toads were treated with either vehicle (peanut 
oil), 46, 62 or 77 mg/kg CPO. CPO significantly inhibited brain FAAH in mice, but had 
no significant effect on toad brain FAAH. Data represent mean specific activity + SEM 
(mouse: n = 5; toad: n = 4). Asterisks indicate a significant difference compared to 
vehicle controls (p < 0.05). 
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Figure 5. Mouse brain carboxylesterase (CbE) activity following acute chlorpyrifos oxon 
(CPO) exposure (ip). Mice were treated with either vehicle (peanut oil), 3.6, 4.7 or 5.9 
mg/kg CPO. Toads were treated with either vehicle (peanut oil), 46, 62 or 77 mg/kg 
CPO. CPO significantly inhibited brain CbE in mice. Carboxylesterase activity was 
undetectable in all toad brains. Data represent mean specific activity + SEM (n = 5). 
Asterisks indicate a significant difference compared to vehicle control (p < 0.05). 
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Figure 6. Mouse and toad liver butyrylcholinesterase (BChE) activities following acute 
chlorpyrifos oxon (CPO) exposure (ip). Mice were treated with either vehicle (peanut 
oil), 3.6, 4.7 or 5.9 mg/kg CPO. Toads were treated with either vehicle (peanut oil), 46, 
62 or 77 mg/kg CPO. CPO had no significant effect on liver BChE of either species. Data 
represent mean specific activity + SEM (mouse: n = 5; toad: n = 4).  
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Figure 7. Mouse and toad liver fatty acid amide hydrolase (FAAH) activities following 
acute chlorpyrifos oxon (CPO) exposure (ip). Mice were treated with either vehicle 
(peanut oil), 3.6, 4.7 or 5.9 mg/kg CPO. Toads were treated with either vehicle (peanut 
oil), 46, 62 or 77 mg/kg CPO. CPO significantly inhibited FAAH activities in the highest 
dose groups in both species. Data represent mean specific activity + SEM (mouse: n = 5; 
toad: n = 4). Asterisks indicate a significant difference compared to vehicle controls (p < 
0.05). 
 
 
 
0 0 .6  0 .8  1
0
5 0 0
1 0 0 0
1 5 0 0
2 0 0 0
2 5 0 0
C h lo rp y rifo s  o x o n  (x  M T D )
A
c
ti
v
it
y
 (
p
m
o
l 
m
in
-1
m
g
-1
) M o u se
T oad
*
*
*
*
32 
 
 
Figure 8. Mouse and toad liver carboxylesterase (CbE) activities following acute 
chlorpyrifos oxon (CPO) exposure (ip). Mice were treated with either vehicle (peanut 
oil), 3.6, 4.7 or 5.9 mg/kg CPO. Toads were treated with either vehicle (peanut oil), 46, 
62 or 77 mg/kg CPO. CPO had no significant effect on liver CbE of either species. Data 
represent mean specific activity + SEM (mouse: n = 5; toad: n = 4).  
 
 
 
 
0 0 .6  0 .8  1
0 .0
0 .2
0 .4
3 0
4 0
5 0
6 0
C h lo rp y rifo s  o x o n  (x  M T D )
A
c
ti
v
it
y
 (
n
m
o
l 
m
in
-1
m
g
-1
)
M o u se
T oad
33 
 
 
Figure 9. Involuntary movements in mice and toads following acute chlorpyrifos oxon 
(CPO) exposure (ip). Mice were treated with either vehicle (peanut oil), 3.6, 4.7 or 5.9 
mg/kg CPO. Toads were treated with either vehicle (peanut oil), 46, 62 or 77 mg/kg 
CPO. CPO significantly increased involuntary movements in mice, but did not cause any 
involuntary movements in toads. Data represent median score with interquartile range 
(mouse: n = 5, toad: n = 4). Asterisks indicate significant difference compared to vehicle 
controls (p < 0.05).  
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Figure 10. Autonomic secretions in mice and toads following acute chlorpyrifos oxon 
(CPO) exposure (ip). Mice were treated with either vehicle (peanut oil), 3.6, 4.7 or 5.9 
mg/kg CPO. Toads were treated with either vehicle (peanut oil), 46, 62 or 77 mg/kg 
CPO. CPO significantly increased SLUD (acronym for salivation, lacrimation, urination 
and defecation) signs in mice, but did not cause any SLUD signs in toads. Data represent 
median score with interquartile range (mouse: n = 5, toad: n = 4). Asterisks indicate 
significant difference compared to vehicle controls (p < 0.05).  
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Figure 11. Stability of mice and toads in tilt test following acute chlorpyrifos oxon (CPO) 
exposure (ip). Mice were treated with either vehicle (peanut oil), 3.6, 4.7 or 5.9 mg/kg 
CPO. Toads were treated with either vehicle (peanut oil), 46, 62 or 77 mg/kg CPO. CPO 
significantly increased stability in toads, but had no effect on stability in mice. Data 
represent mean incline maintained + SEM (mouse: n = 5; toad: n = 4). Asterisks indicate 
significant difference compared to vehicle controls (p < 0.05). 
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In vitro Studies 
The IC50 values are summarized in Table 2. In all cases, AChE in toad tissues was 
markedly less sensitive to inhibition in vitro compared to mouse tissues. IC50 values in 
toad brain were 15-fold higher with CPO (Figure 12), 367-fold higher with paraoxon 
(Figure 13) and 32-fold higher with naled (Figure 14) compared to those in mouse brain 
tissue. Control AChE activities at 26°C were reduced compared to 37°C in both species. 
The IC50 for toad brain AChE with CPO at 26°C was 37-fold greater compared to mouse 
(Figure 15). In toad, the IC50 with CPO at 26°C was significantly higher compared to the 
IC50 at 37°C (226 vs 136 nM; p = 0.001). In contrast, there was no difference between the 
mouse brain AChE IC50 with CPO at 26 and 37°C (6.7 vs 9.0 nM; p = 0.26).   
While there was no significant difference in brain AChE Vmax between mouse (1.1 
+ 0.055 nmol min
-1
) and toad (0.90 + 0.075; p = 0.49), Km for toad (0.23 + 0.054 mM) 
was 5-fold higher compared to mouse (0.043 + 0.0094 mM; p = 0.002; Figure 16).  
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Species 
Chlorpyrifos 
oxon - 37°C (nM) 
Chlorpyrifos 
oxon - 26°C (nM) 
Paraoxon - 37°C 
(nM) 
Naled - 37°C 
(nM) 
Mouse 
9.00  
(6.98 – 11.6) 
6.70  
(6.08 – 7.40) 
15.7  
(11.8 – 21.0) 
53.8  
(50.0 – 58.3) 
Toad 
136  
(108 – 172) 
226  
(159 – 320) 
5756  
(5088 – 6511) 
1705  
(1401 – 2075) 
 
Table 2. Sensitivity of acetylcholinesterase (AChE) in mouse and toad brain to inhibition 
by selected inhibitors in vitro. IC50 values are shown as mean (95% confidence interval). 
Toad brain AChE exhibits higher IC50 values for all inhibitors. Data are from 3 
independent replicates (n = 4 for paraoxon in toad brain).  
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Figure 12. Comparison of mouse and toad brain acetylcholinesterase (AChE) inhibition 
by chlorpyrifos oxon (CPO) in vitro. Tissues were pre-incubated (37°C, 20 min) with 
either vehicle or varying concentrations of CPO (0.3 – 500 nM) and residual activity 
measured as described in methods. Data are expressed as % of control values (mouse: 
0.32 + 0.024 nmol/min; toad: 0.32 + 0.026 nmol/min). Data represent mean + SEM (n = 
3 for each species). Mean IC50 (95% confidence interval) for mouse: 9.00 (6.98 – 11.6) 
nM; toad: 136 (108 – 172) nM. 
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Figure 13. Comparison of mouse and toad brain acetylcholinesterase (AChE) inhibition 
by paraoxon (PO) in vitro. Tissues were pre-incubated (37°C, 20 min) with either vehicle 
or varying concentrations of PO (1 – 50,000 nM) and residual activity measured as 
described in methods. Data are expressed as % of control values (mouse: 0.35 + 0.026 
nmol/min; toad: 0.36 + 0.050 nmol/min). Data represent the mean + SEM (mouse: n = 3; 
toad: n = 4). Mean IC50 (95% confidence interval) for mouse: 15.7 (11.8 – 21.0) nM; 
toad: 5756 (5088 – 6511) nM.  
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Figure 14. Comparison of mouse and toad brain acetylcholinesterase (AChE) inhibition 
by naled in vitro. Tissues were pre-incubated (37°C, 20 min) with either vehicle or 
varying concentrations of naled (1 – 5000 nM) and residual activity measured as 
described in methods. Data are expressed as % of control values (mouse: 0.36 + 0.10 
nmol/min; toad: 0.22 + 0.0049 nmol/min). Data represent mean + SEM (n = 3 for each 
species). Mean IC50 (95% confidence interval) for mouse: 53.8 (49.6 – 58.3) nM; toad: 
1705 (1401 – 2075) nM. 
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Figure 15. Comparison of mouse and toad brain acetylcholinesterase (AChE) inhibition 
by chlorpyrifos oxon (CPO) in vitro at 26°C. Tissues were pre-incubated (26°C, 20 min) 
with either vehicle or varying concentrations of CPO (0.3 – 500 nM) and residual activity 
measured as described in methods. Data are expressed as % of control values (mouse: 
0.1997 + 0.00465 nmol/min; toad: 0.1939 + 0.01399 nmol/min). Data represent mean + 
SEM (n = 3 for each species). Mean IC50 (95% confidence interval) for mouse AChE: 
6.70 (6.08 – 7.40) nM; toad AChE: 226 (159 – 320) nM. 
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Figure 16. Kinetic evaluation of substrate hydrolysis by mouse and toad brain 
acetylcholinesterase (AChE) in vitro. Tissues were incubated with varying concentrations 
of acetylthiocholine (0.01 – 1 mM) and AChE activity was measured as described in 
methods. Data represent the mean + SEM (mouse: n = 4, toad: n = 3). There was no 
significant difference in Vmax between mouse (1.1 + 0.055 nmol min
-1
) and toad (0.90 + 
0.075; p = 0.49). Km for toad (0.23 + 0.054 mM) was significantly higher compared to 
mouse (0.043 + 0.0094 mM; p = 0.002).  
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OP Inactivation Assay and OP-Sensitive Proteins 
Mouse and toad brain homogenates were pre-incubated with varying 
concentrations of CPO. The ability of each tissue to inactivate CPO was then evaluated 
by adding purified BChE as a marker enzyme and measuring residual activity. Toad brain 
homogenate was substantially more effective at detoxifying CPO than mouse brain 
(Figure 17). Pre-incubation with toad brain tissue increased the IC50 for BChE with CPO 
by roughly 118-fold: from 31.5 (28.2 – 35.1) nM to 3,698 (very wide) nM, while pre-
incubation with mouse brain only increased IC50 for BChE to 45.2 (40.1 – 51.0) nM.  
We screened brain tissues of mouse and toad for CPO-sensitive proteins using a 
fluorescent serine hydrolase probe. Toad brain contains at least one protein (~50 kD) that 
is sensitive to binding CPO at 10 nM. This protein was not observed in mouse brain 
(Figure 18). 
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Figure 17. Inactivation of chlorpyrifos oxon (CPO) by mouse and toad brain homogenate. 
Mouse and toad brain tissues were incubated with either buffer or one of a range of CPO 
concentrations (3 – 800 nM). A marker enzyme (purified recombinant human BChE, 250 
ng) was then added and residual activity was measured as described in the methods. Toad 
brain tissue was more effective at inactivating CPO than tissue from mouse. Data are 
presented as mean + SEM (n = 3 for each group). 
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Figure 18. In vitro effects of chlorpyrifos oxon (CPO) on organophosphate-sensitive 
proteins in mouse and toad brain. Mouse and toad brain membrane pellets were incubated 
with either vehicle or varying concentrations of CPO (1, 10, 100 nM). A fluorescent 
serine hydrolase marker (FP-rhodamine, 4 µM final) was then added and incubated for 30 
min (23°C). Samples (10 µl/well) were separated on a 10% polyacrylamide gel (0.1% 
SDS) with a 4.5% stacking gel at 120 V for two hours as described in methods. Gels were 
fluorometrically visualized using a Cy 3 filter (excitation: 552 nm, emission: 575 nm). 
Fluorescent bands suggest the presence of a serine hydrolase; decrease in band density 
suggests binding by CPO. Toad brain contains a CPO-sensitive protein (~50 kD, marked 
by arrow) not observed in mouse brain. 
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CHAPTER IV 
 
 
DISCUSSION 
 
In vivo Comparisons 
 Toads tolerated much higher doses of CPO than mice (MTDs: 77 vs. 5.9 mg/kg). 
At equi-toxic doses (based on MTD), mice displayed dose-related brain AChE inhibition, 
while there was no inhibition of toad brain AChE. The lack of AChE inhibition in treated 
toads suggests that toads are less sensitive than mice to acute OP toxicity because AChE 
is not inhibited by CPO. While we also observed dose-related inhibition of BChE, 
MAGL, FAAH and CbE in mouse brain, there was no inhibition of any of these enzymes 
in toad brain, suggesting that toads more readily detoxify CPO compared to mice. 
Previous studies have suggested that CbE plays a role in the inactivation of OPs in 
amphibians (Caballero de Castro et al., 1991; Attademo et al., 2014; Attademo et al., 
2017), but the lack of CbE in toad brain and the relatively low liver activity compared to 
mice in our study suggests that CbE does not play a prominent role in inactivation of 
CPO in toads. Furthermore, toad liver CbE was not affected by CPO, consistent with the 
findings of Robles-Mendoza et al., (2011), who reported that CbE in juvenile axolotls 
was less sensitive than AChE to chlorpyrifos in vivo. 
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Interestingly, liver FAAH activity was significantly reduced by CPO in both 
species. Fatty acid amide hydrolase inhibition in toad liver might suggest that FAAH is 
more sensitive than AChE in toads. Because toad brain FAAH was unaffected by CPO, it 
is unlikely that FAAH is responsible for “protecting” brain AChE by binding to CPO. 
Previous studies indicated that in rats, DFP was a more potent in vivo FAAH inhibitor 
than expected based on in vitro sensitivity, implying an indirect modulation of FAAH 
may occur (Nallapaneni et al., 2006; Nallapaneni et al., 2008). It is possible that CPO 
toxicity indirectly depresses toad liver FAAH activity rather than via phosphylation and 
direct inhibition. Future studies should investigate FAAH as a sensitive endpoint for OP 
toxicity in amphibians.  
There were also differences in functional signs between treated mice and toads. 
At equi-toxic doses (based on MTDs), mice displayed classic signs of cholinergic toxicity 
while few signs were noted in toads. In mice that received high doses of CPO, we noted 
increased tremors/involuntary movements consistent with previous reports of acute OP 
toxicity (Gaines, 1960; Liu and Pope, 1996). Though some authors have reported tremors 
in bullfrogs (Rana catesbeiana) following DFP exposure (Edery and Schatzberg-Porath, 
1960), we did not observe any involuntary movements or muscle fasciculations in any 
toads. Instead, toads treated with high doses showed pronounced hypo-activity, consistent 
with Wilber (1954) who noted severe depression in bullfrogs following acute sarin 
exposure. More recently, there have been reports of decreased motor activity in 
amphibians following OP exposure (Robles-Mendoza et al., 2011). Similar hypo-activity 
has been reported in tadpoles exposed to OPs (Watson et al., 2014) and these decreases in 
motor activity were not correlated with AChE inhibition.  
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In mice that received higher doses of CPO, we noted increased SLUD signs 
consistent with previous studies (Gaines, 1960; Liu and Pope, 1996); however, we did not 
observe increased secretions in toads. During the acute lethality studies, toads that 
received a lethal dose (100 mg/kg) of CPO displayed miosis and extensive parotoid 
secretions. No brain or liver AChE inhibition was noted in these toads. Chlorpyrifos oxon 
has been reported to act as direct muscarinic receptor agonist (Huff et al., 1994). It may 
be that CPO acts directly as a cholinergic agonist at high doses to stimulate the parotoid 
glands and pupillary sphincters in the absence of AChE inhibition. We also noted 
erythema in the seat patch region of toads that received higher doses (> 62 mg/kg) 
consistent with previous observations (Wilber 1954).  
We predicted that, due to a loss of coordination, intoxicated animals would slide 
to the bottom of the cage at lower inclines in the tilt test. Chlorpyrifos oxon did not 
significantly decrease the angle at which mice slid, despite the conspicuous increase in 
involuntary movements. Surprisingly, intoxicated toads actually had increased stability 
according to the tilt test. Chlorpyrifos oxon intoxication may depress motor function in 
toads, preventing the evasive response noted in control animals. The absence of response 
may allow the toads to adhere passively to the bottom of the cage and thus appear to have 
greater stability in the tilt test. Future studies should continue to pursue behavioral 
endpoints for toxicity in amphibians; however, our data suggest that this tilt test is not an 
appropriate endpoint for OP toxicity in mice or toads. 
It should be noted that in mammals the primary cause of mortality is respiratory 
depression via disruption in the respiratory control center of brain, exacerbated by 
increased bronchial secretions and loss of diaphragm contractions (De Candole et al., 
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1953; Pope, 2006). In contrast, amphibians are not as reliant on constant ventilation and 
maintain continuous exchange of oxygen through skin, making them resistant to hypoxia 
(Gargaglioni and Milsom, 2007). Given the lack of AChE depression in toad brain, it is 
unlikely that disruption of ventilation control occurred, and even if it did, toads would 
likely be able to withstand hypoxic conditions for several hours without dying from 
asphyxiation.  
 In summary, toads were much less sensitive than mice to acute CPO toxicity in 
vivo and did not experience the same degree of enzyme inhibition at equi-toxic doses of 
CPO. These data suggest that toads are less sensitive to acute toxicity because AChE is 
not inhibited by CPO in vivo. The comparatively low activity and sensitivity of toad CbE 
suggests that this enzyme does not play a prominent role in the inactivation of CPO. The 
lack of enzyme inhibition in toads may suggest that toads have a greater ability to 
detoxify CPO than mouse.  
In vitro Comparisons 
Acetylcholinesterase in toad brain was significantly less sensitive than mouse 
brain AChE to inhibition with all inhibitors. These findings are consistent with other in 
vitro studies that demonstrate the relative insensitivity of amphibian AChE to inhibition 
by OPs and other anticholinesterases (Andersen et al., 1977; Wang and Murphy, 1982; 
Ferrari et al., 2004). Toads may be less sensitive to acute OP toxicity compared to mice 
because toad AChE is less sensitive to inhibition. We also evaluated sensitivity of mouse 
and toad AChE to inhibition by CPO at 26°C to determine if temperature influenced 
relative sensitivity. Both species had lower basal enzyme activities at 26°C compared to 
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reactions at 37°C, which is consistent with accepted models of enzyme reactions (i.e., the 
Q10 rule; Wolfenden et al., 1999). Interestingly, the IC50 for toad AChE with CPO was 
greater at 26°C compared to 37°C, while there was no significant difference in the mouse 
enzyme sensitivity at the different temperatures. As ectotherms, toads may express 
isoforms of enzymes that are more active at 26°C than 37°C. It may be that such an 
enzyme binds CPO, and thus increases the IC50 for CPO at 26°C relative to 37°C. 
There were some kinetic differences between mouse and toad brain AChE. With 
acetylthiocholine as substrate, there was no difference in Vmax, but the toad enzyme had a 
significantly higher km compared to mouse enzyme, indicating that the toad enzyme 
requires a higher concentration of substrate to reach maximal activity. This finding agrees 
with that of Zahavi et al. (1971), who reported higher Km of toad AChE with 
acetylthiocholine compared to several arthropod species and proposed that active site 
gorge modifications may alter substrate (and inhibitor) access. The comparatively low 
efficiency of toad AChE reflects phylogenetic differences between mouse and toad; it 
may also influence the rate at which inhibitors access the active site.  
While IC50s are often used to compare sensitivity of enzymes in different tissues, 
genders and species, etc., it does not necessarily reflect the inherent sensitivity of the 
enzyme itself. Mortensen et al., (1998) demonstrated that when enzymes are immuno-
precipitated from disparate tissues, tissue-related differences in IC50s disappeared, 
suggesting that the tissue environment around an enzyme could play a role in sensitivity 
to inhibition. While we have not immuno-precipitated AChE from the tissues in this 
study, our IC50 data suggest that, in its native tissue (environment), toad AChE is far less 
sensitive than mouse, possibly due to intrinsic detoxification differences.  
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Toad brain tissue was far more effective at inactivating CPO than mouse brain. 
This suggests that there may be tissue proteins within the toad brain that serve to protect 
AChE from inhibition by OPs. These could be enzymes that function as “suicide” 
inactivators by binding OPs stoichiometrically and thus prevent them from binding 
AChE. Several authors have suggested that amphibians possess a greater ability than 
mammals to inactivate OPs following exposure (Edery and Schatzberg-Porath, 1960; 
Robles-Mendoza et al., 2011); our findings support this hypothesis, i.e., that the toad 
brain contains proteins that can inactivate CPO.  
To characterize any proteins in toad brain that might contribute to local OP 
inactivation in brain, we screened for OP-sensitive proteins using a fluorescent serine 
hydrolase probe. There is at least one protein expressed in toad brain that is sensitive to 
binding by CPO at around 10 nM. Such a protein could contribute to the comparatively 
high IC50 values for OPs with toad AChE; it may also be responsible for the relatively 
high CPO inactivation noted in toad brain tissue. If this protein is similarly sensitive to 
OP binding in vivo, it may also contribute to the toads’ comparatively low acute 
sensitivity and lack of AChE inhibition following CPO exposure.  
In conclusion, our findings demonstrate that the Great Plains toad is less sensitive 
to acute CPO toxicity than outbred mouse, and that differential sensitivity of AChE may 
contribute to this species difference. We provide evidence that toad brain tissue is 
markedly more effective at inactivating CPO compared to mouse brain tissue, which may 
contribute to differences in sensitivity in vitro and in vivo. Furthermore, our findings 
suggest there are additional proteins in toad brain that may contribute to comparatively 
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higher OP inactivation leading to lesser AChE sensitivity. Identification of this protein 
may lead to an OP biomarker and a better understanding of OP toxicity in amphibians. 
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CHAPTER V 
 
 
SUMMARY AND CONCLUSIONS 
 
 Toads were far less sensitive to acute CPO toxicity compared to mice.  
 While mice displayed dose-related inhibition of brain AChE, BChE, MAGL, FAAH 
and CbE activities, no significant inhibition of these enzymes was observed in toad 
brain.  
 There was no detectable CbE activity in toad brain and low activity in liver relative to 
mouse, suggesting that in toads, CbE is not a major contributor to OP inactivation. 
 After acute CPO exposure, FAAH was significantly inhibited in the liver of both 
species, possibly representing a new biomarker for OP toxicity in amphibians. 
 Toad AChE was markedly less sensitive to in vitro inhibition by CPO, paraoxon and 
naled compared to mouse, which suggests that sensitivity of the target enzyme may 
contribute to sensitivity in vivo.  
 Toad brain tissue was substantially more effective at detoxifying CPO than mouse 
brain. This finding suggests that there are macromolecules in toad brain able to 
sequester or hydrolyze OPs. 
 There is one protein in toad brain sensitive to CPO at 10 nM. This protein may 
contribute to more effective inactivation of OPs in toad brain.
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